Keck School of Medicine of USC, LA

Read Bio

Trevor E Angell, MD is Associate Professor of Clinical Medicine in the Division of Endocrinology and Diabetes, at the Keck School of Medicine of USC, Los Angeles, California, where he serves as Medical Director of the Thyroid Center. He completed his M.D. and clinical training at the Keck School of Medicine and Los Angeles General Medical Center, including research fellowship studying thyroid cancer immunology. He joined the endocrinology division at Brigham and Women’s Hospital and Harvard Medical School, where he conducted clinical and translational research on the diagnostic evaluation of thyroid nodules and thyroid cancer, before returning to USC where he is now. His current clinical and research activities focus on the diagnosis and management of thyroid nodules and cancer, as well as functional thyroid diseases. Dr. Angell is a current member of the American Thyroid Association’s thyroid nodule guidelines taskforce, and is Editor-in-Chief of Clinical Thyroidology.

Harvard University

Bio TBC

University of Adelaide

Read bio

Sunita De Sousa is an Associate Professor at the University of Adelaide and Senior Staff Specialist in Endocrinology and Genetics at the Royal Adelaide Hospital. She completed her PhD on prolactinomas in 2020, receiving the University of Adelaide Doctoral Research Medal. Her ongoing research interests include pituitary tumours, multiple endocrine neoplasia and monogenic diabetes. She recently co-chaired the ANZ guidelines on genetic testing for monogenic diabetes and is now chairing the International Pituitary Society Genetics Guidelines Working Group. To support the emerging subspecialty of endocrine genetics, Sunita founded the EndoGen National Endocrine Genetics Network including a regular national MDT meeting. She is the current Secretary of the Endocrine Society of Australia.

University of Sydney

READ BIO

Professor Jenny Gunton completed her medical degree at University of Queensland followed by Endocrinology and Diabetes Specialist training and then a PhD in Molecular Biology with University of Sydney. Her post-doctoral studies were in the laboratory of Prof C Ron Kahn at Joslin Diabetes Centre and Harvard Medical School.

Professor Gunton is currently the President-Elect for the Endocrine Society of Australia. She is the Director of the Centre for Diabetes and Obesity Research at the Westmead Institute for Medical Research and Chair of Medicine at Westmead Hospital, The University of Sydney. Prof Gunton’s clinical interests include diabetes, obesity, and brittle bone disease. Her research focusses on beta-cell function, islet transplantation and the intersection of transcription factors and their regulation by nutrients including iron and Vitamin D. Prof Gunton holds an Investigator Grant, Leadership Level 2.

University of Western Australia

Read Bio

Professor Jones is a renowned clinician researcher in the field of paediatric diabetes.

As Co-Director of the Children’s Diabetes Centre, a JDRF Global Centre of Excellence that integrates clinical and research capabilities, he is focused on improving outcomes for children with diabetes through innovative approaches and collaborations with a translational focus and is also the Director of Research at Perth Children’s Hospital.

Providing national leadership in clinical, research and advocacy roles, Professor Jones is internationally recognised as a leader in his field. His clinical diabetes service was the first in Australia to introduce insulin pumps in paediatric care which led to a paradigm shift in clinical practice. Professor Jones was an integral part of the successful lobby for Federal funding for continuous glucose monitoring technology for T1D patients under 21 years in Australia. He co-authored the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines for management of hypoglycaemia.

University of California, Los Angeles

Read bio

Melissa G. Lechner, MD, PhD is an Assistant Professor of Medicine in the Division of Endocrinology at the University of California Los Angeles.  After combined M.D./Ph.D. training at the USC Keck School of Medicine, she completed a combined residency in internal medicine and paediatrics at the Harvard Medical School hospitals and a clinical fellowship in endocrinology at UCLA. Dr. Lechner’s clinical and research focus is on understanding mechanisms of spontaneous and cancer therapy associated autoimmunity, with a focus on endocrine organs. She established the Onco-Endocrinology clinic and UCLA Immunotherapy Toxicity team and serves on the National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO) Management of Immunotherapy Toxicities guidelines panels.  

Read bio

Pamela Lincoln is currently a wine producer based in Albany, WA but previously trained as a Dietitian with a Master's Degree in Public Health from Curtin University.  She was diagnosed with Conns/Primary Aldosteronism almost 3 years ago after only a short duration of symptoms - thanks mostly to one of Dr Norman Swan's Health Report programs which featured an item on PA, following the publication of some important research conducted in primary care in Australia.  Pamela is grateful that her condition did not go untreated for the typical period (often years), and that she therefore has no end-organ damage.  She hopes that one day all patients will receive rapid diagnoses, and adequate treatment with correct medication (or surgery if suitable) and is volunteering on several research projects and PACE as a consumer representative to try to hasten this.

Royal Adelaide Hospital

Read Bio

Dr James McNeil is a dual trained Endocrinologist and Nuclear Medicine Physician at the Royal Adelaide Hospital and Jones Radiology. James graduated from Adelaide University with MBBS in 2015, obtained dual specialist fellowship of the Australasian College of Physicians in 2023. His clinical and academic interests are at the intersection of Nuclear Endocrinology with particular interest in Endocrine oncology imaging and theragnostics. In 2024, he completed further post-fellowship research at Royal North Shore Hospital as the Thyroid Cancer Fellow. He is currently undertaking PhD studies through the University of Adelaide examining novel applications of molecular imaging in pituitary tumours, supported by the Endocrine Society of Australia Higher Degree Research Scholarship and grant funding from the Neurosurgical Research Foundation and ANTSO/ANZSNM.

The University of Western Australia

Read Bio

Prof Markus Schlaich is a renal physician and a European Society of Hypertension (ESH) accredited hypertension specialist. Markus is Chair of Hypertension Australia and Co-Chair of the National Hypertension Taskforce. He has a strong background in clinical research with a focus on the pathophysiology of hypertension, the role of the sympathetic nervous system, involvement of the kidneys, and hypertension mediated organ damage. He has a specific interest in treatment modalities targeting the sympathetic nervous system and has been a pioneer of renal denervation and other interventional approaches. He has authored more than 500 articles in peer reviewed journals and serves on the Editorial Board of Hypertension, Journal of Hypertension, and Hypertension Research.

Western Sydney University

READ BIO

Distinguished Professor David Simmons is Chief Medical Officer for Diabetes Australia, Professor of Medicine at Western Sydney University, District Advisor on Diabetes for the South Western Sydney Local Health District and previous Director of the Macarthur Diabetes Endocrinology and Metabolism Service in Sydney, Australia. Before returning to Australia in 2014, Professor Simmons was the Clinical lead for the Diabetes service at Addenbrookes Hospital, Cambridge UK. With over 500 refereed publications, he has won several national and international awards for his work in diabetes epidemiology, diabetes in pregnancy and diabetes service development including the American Diabetes Association 2020 Norbert Freinkel Award, 2022 Diabetes in Pregnancy Study Group Pederson Award and 2025 International Diabetes Epidemiology Group Peter Bennett Award.  He is the immediate past president of the Australasian Diabetes in Pregnancy Society (ADIPS). He is the Chief Investigator for APHLID, an RCT of a mental health/diabetes app in young adults with type 1 diabetes, the TOBOGM study the first large RCT of diagnosing and treating early gestational diabetes mellitus and Australian Chief Investigator for the CIRCUIT RCT of closed loop in pregnancies complicated by Type 1 diabetes and the CORDELIA RCT of CGM in GDM. He remains a practising endocrinologist holding weekly diabetes in pregnancy clinics.

Hudson Institute of Medical Research

Read Bio

A/Professor Jun Yang is the Head of the Endocrine Hypertension Group at Hudson Institute of Medical Research, a Consultant Endocrinologist at Monash Health, and a Senior Researcher in the Department of Medicine at Monash University, Victoria, Australia.   Jun graduated from Monash University with a MBBS (Hon) in 2001, attained her FRACP in 2010, and completed a PhD in 2013 focusing on tissue-selective coregulators of the mineralocorticoid receptor (MR). She has since advanced basic and clinical research in the field of MR-driven cardiovascular disease, particularly primary aldosteronism, contributing to 131 original publications.  She established Victoria’s first Endocrine Hypertension Service, co-leads the Primary Aldosteronism Centre of Excellence, and enjoys fostering national and international collaborations to enhance the detection and management of primary aldosteronism for better patient outcomes.

Baker Heart and Diabetes Institute

Read bio

Prof Morag Young is co-lead of the Baker HDI Heart Failure Program and head of the Cardiovascular Endocrinology Laboratory. She is internationally recognised for her work defining the pathophysiology of the mineralocorticoid receptor (MR) in the heart and non-epithelial cell types. Prof Young took her PhD studies at the Baker Institute under the supervision of Professor John Funder investigating the pathophysiology of MR signalling in the heart and vasculature. Working with Prof Funder she was one of the first to demonstrate a direct cardiac mechanism of MR activation in cardiovascular disease (JCI 1994 >580 total cits). As a C.J. Martin postdoctoral scientist, she trained with the late Professor Keith Parker at UT Southwestern Medical Centre, Texas. During this period, she developed new transgenic mouse models and identified a new model of hypothalamic obesity (Endocrinol 2002, >320 cits). Upon returning to Australia she continue her post-doctoral training with Associate Professor Tim Cole which enabled the creation of novel cell-selective knockout models of the MR. In 2002, she was recruited to Prince Henry’s Institute of Medical Research (now Hudson Institute of Medical Research) to work with Professor Peter Fuller and established her laboratory and a discovery research program to identify novel mechanisms of MR action in cardiovascular disease, including cell-selective pathways in macrophages, cardiomyocytes, and endothelial cells that are relevant to both males and females. Most recently, this work has uncovered a highly novel interaction between the MR and the molecular clock in the pathogenesis of cardiovascular disease. In 2000 Prof Young was recruited to the Baker HDI as the inaugural Alice Baker and Eleanor Shaw Gender Equity Fellow. Her 2023 Nat Comms paper demonstrated an independent role for circadian disruption on blood pressure that was sex specific. More recent discoveries from the Young group include the highly novel discovery of a functional interaction between the MR and the molecular clock and importance of non-canonical signalling pathways for the MR in macrophages, both of which are central to the development of cardiovascular disease. Prof Young is a CI for the PACE Centre of Research Excellence and leads preclinical research for the program and has been supported by >$7,110,000 in funding as CIA. She has trained over 20 PhD students and ECRS, and over 30 undergraduate research scientists.

University of Western Australia

Bio TBC

Melbourne Thyroid Surgery

Bio TBC

Bio TBC

University of Sydney

BIO TBC

University of Sydney

Bio TBC

University of Sydney

Bio TBC

University of Melbourne

Bio tbc

UNSW Sydney

Bio tbc